- $3.08m
- $10.31m
- $23.07m
- 48
- 86
- 21
- 51
Annual income statement for Cyanotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 31.9 | 32.3 | 36 | 23.2 | 23.1 |
| Cost of Revenue | |||||
| Gross Profit | 12.7 | 11.1 | 13.6 | 7.26 | 5.95 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 30.8 | 30.9 | 33.4 | 26.1 | 27.7 |
| Operating Profit | 1.05 | 1.47 | 2.57 | -2.92 | -4.59 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 0.396 | 0.923 | 2.18 | -3.42 | -5.26 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.387 | 0.92 | 2.15 | -3.44 | -5.27 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.387 | 0.92 | 2.15 | -3.44 | -5.27 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.387 | 0.92 | 2.15 | -3.44 | -5.27 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.065 | 0.009 | 0.353 | -0.55 | -0.806 |